Poxel SA
POXEL.PA
| Exchange: | PA |
| Currency | Euro |
| ISIN: | FR0012432516 |
| Primary Ticker: | POXEL.PA |
| Fiscal Year End: | December |
| International Domestic: | International |
| Sector: | Healthcare |
| Industry: | Biotechnology |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and Deute Rx LLC for the development of PXL065, a mitochondrial dysfunction; and Sumitomo Pharma for development and commercialization of Imeglimin. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France. |
| Address: | Immeuble Le Sunway, Lyon, France, 69007 |
| Website: | https://www.poxelpharma.com |
| Full Time Employees: | 6 |
| Updated On: | 2024-11-04 |
Highlights
| Market Capitalization: | 15026511 |
| Market Capitalization Mln: | 15.02 |
| EBITDA: | -11989000 |
| Wall Street Target Price: | 3.5 |
| Book Value: | -1.27 |
| Earnings Share: | -1.05 |
| Most Recent Quarter: | 2023-12-31 |
| Operating Margin TTM: | -5.35 |
| Return On Assets TTM: | -0.90 |
| Return On Equity TTM: | -3.23 |
| Revenue TTM: | 1981000 |
| Revenue Per Share TTM: | 0.05 |
| Quarterly Revenue Growth YOY: | 0.73 |
| Gross Profit TTM: | 13338000 |
| Diluted Eps TTM: | -1.05 |
Valuation
| Price Sales TTM: | 7.58 |
| Price Book MRQ: | 5.34 |
| Enterprise Value: | 59797430 |
| Enterprise Value Revenue: | 30.18 |
| Enterprise Value Ebitda: | -1.55 |
Shares
| Shares Outstanding: | 53285500 |
| Shares Float: | 44172054 |
| Percent Insiders: | 3.17 |
| Percent Institutions: | 7.98 |
Technicals
| Beta: | 1.61 |
| 52 Week High: | 0.89 |
| 52 Week Low: | 0.26 |
| 50 Day MA: | 0.44 |
| 200 Day MA: | 0.53 |
Earnings
| Report Date: | 2025-04-07 |
| Date: | 2025-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2024-12-09 |
| Date: | 2024-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2024-02-15 |
| Date: | 2023-12-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Estimate: | -0.43 |
| Eps Difference: | 0.43 |
| Surprise Percent: | 10 |
| Report Date: | 2023-11-08 |
| Date: | 2023-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2023-08-30 |
| Date: | 2023-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.42 |
| Eps Estimate: | -0.42 |
| Report Date: | 2023-05-03 |
| Date: | 2023-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Estimate: | -0.23 |
| Eps Difference: | 0.23 |
| Surprise Percent: | 10 |
| Report Date: | 2023-03-23 |
| Date: | 2022-12-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | -0.62 |
| Eps Estimate: | -0.2 |
| Eps Difference: | -0.42 |
| Surprise Percent: | -21 |
| Report Date: | 2022-10-04 |
| Date: | 2022-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2022-08-08 |
| Date: | 2022-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.46 |
| Eps Estimate: | -0.61 |
| Eps Difference: | 0.15 |
| Surprise Percent: | 24.59 |
| Report Date: | 2022-05-17 |
| Date: | 2022-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2022-03-23 |
| Date: | 2021-12-31 |
| Currency: | EUR |
| Eps Actual: | -0.55 |
| Eps Estimate: | -0.98 |
| Eps Difference: | 0.43 |
| Surprise Percent: | 43.87 |
| Report Date: | 2021-10-20 |
| Date: | 2021-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2021-07-21 |
| Date: | 2021-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.28 |
| Eps Estimate: | -0.21 |
| Eps Difference: | -0.07 |
| Surprise Percent: | -33.33 |
| Report Date: | 2021-04-21 |
| Date: | 2021-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2021-03-24 |
| Date: | 2020-12-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.69 |
| Eps Estimate: | -0.77 |
| Eps Difference: | 0.08 |
| Surprise Percent: | 10.38 |
| Report Date: | 2020-10-20 |
| Date: | 2020-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2020-07-21 |
| Date: | 2020-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.45 |
| Eps Estimate: | -0.66 |
| Eps Difference: | 0.21 |
| Surprise Percent: | 31.81 |
| Report Date: | 2020-05-25 |
| Date: | 2020-03-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2020-03-26 |
| Date: | 2019-12-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.77 |
| Eps Difference: | -0.77 |
| Report Date: | 2019-10-07 |
| Date: | 2019-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2019-07-15 |
| Date: | 2019-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.22 |
| Eps Difference: | -0.22 |
| Report Date: | 2019-04-08 |
| Date: | 2019-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2019-03-22 |
| Date: | 2018-12-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 0.23 |
| Eps Difference: | 0.23 |
| Report Date: | 2018-10-16 |
| Date: | 2018-09-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2018-09-19 |
| Date: | 2018-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 0.3 |
| Report Date: | 2018-04-23 |
| Date: | 2018-03-31 |
| Currency: | EUR |
| Report Date: | 2018-03-23 |
| Date: | 2017-12-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | -0.55 |
| Report Date: | 2017-08-24 |
| Date: | 2017-06-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | -0.42 |
| Date: | 2024-12-31 |
| Period: | +1y |
| Growth: | 2.02 |
| Earnings Estimate Year Ago Eps: | -0.90 |
| Earnings Estimate Growth: | 2.02 |
| Revenue Estimate Avg: | 56800000.00 |
| Revenue Estimate Low: | 56800000.00 |
| Revenue Estimate High: | 56800000.00 |
| Revenue Estimate Number Of Analysts: | 1.00 |
| Revenue Estimate Growth: | 34.50 |
| Eps Trend7days Ago: | 0.92 |
| Eps Trend30days Ago: | 0.92 |
| Eps Trend60days Ago: | 0.92 |
| Eps Trend90days Ago: | 0.92 |
| Date: | 2023-12-31 |
| Growth: | 0.16 |
| Earnings Estimate Year Ago Eps: | -1.08 |
| Earnings Estimate Growth: | 0.16 |
| Revenue Estimate Avg: | 1600000.00 |
| Revenue Estimate Low: | 1600000.00 |
| Revenue Estimate High: | 1600000.00 |
| Revenue Estimate Number Of Analysts: | 1.00 |
| Revenue Estimate Growth: | 1.37 |
| Eps Trend7days Ago: | -0.90 |
| Eps Trend30days Ago: | -0.90 |
| Eps Trend60days Ago: | -0.90 |
| Eps Trend90days Ago: | -0.90 |
| Date: | 2023-09-30 |
| Revenue Estimate Avg: | 664000.00 |
| Revenue Estimate Growth: | 2.27 |
| Date: | 2022-12-31 |
| Period: | +1y |
| Growth: | -0.75 |
| Earnings Estimate Year Ago Eps: | -0.74 |
| Earnings Estimate Growth: | -0.75 |
| Revenue Estimate Avg: | 674000.00 |
| Revenue Estimate Low: | 700000.00 |
| Revenue Estimate High: | 8000000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | -0.95 |
| Eps Trend7days Ago: | -1.20 |
| Eps Trend30days Ago: | -1.20 |
| Eps Trend60days Ago: | -1.20 |
| Eps Trend90days Ago: | -1.20 |
| Date: | 2022-03-31 |
| Period: | +1q |
| Revenue Estimate Avg: | 32000.00 |
| Date: | 2021-12-31 |
| Revenue Estimate Avg: | 13397000.00 |
| Revenue Estimate Low: | 13400000.00 |
| Revenue Estimate High: | 47000000.00 |
| Revenue Estimate Number Of Analysts: | 3.00 |
| Revenue Estimate Growth: | 0.96 |
| Eps Trend7days Ago: | -0.74 |
| Eps Trend30days Ago: | -0.74 |
| Eps Trend60days Ago: | -0.74 |
| Eps Trend90days Ago: | -0.74 |
| Date: | 2019-12-31 |
| Period: | +1y |
| Revenue Estimate Avg: | 29500000.00 |
| Revenue Estimate Low: | 10000000.00 |
| Revenue Estimate High: | 46000000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | -0.47 |
| Eps Trend7days Ago: | -0.40 |
| Eps Trend30days Ago: | -0.40 |
| Eps Trend60days Ago: | -0.40 |
| Eps Trend90days Ago: | -0.40 |
| Date: | 2019-06-30 |
| Period: | +1q |
| Revenue Estimate Avg: | 56080000.00 |
| Revenue Estimate Low: | 28000000.00 |
| Revenue Estimate High: | 70000000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 9.60 |
| Date: | 2019-03-31 |
| Revenue Estimate Avg: | 56080000.00 |
| Revenue Estimate Low: | 28000000.00 |
| Revenue Estimate High: | 70000000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 9.60 |
| Date: | 2018-12-31 |
| Revenue Estimate Avg: | 56080000.00 |
| Revenue Estimate Low: | 28000000.00 |
| Revenue Estimate High: | 70000000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 9.60 |
| Eps Trend7days Ago: | 0.20 |
| Eps Trend30days Ago: | 0.20 |
| Eps Trend60days Ago: | 0.20 |
| Eps Trend90days Ago: | 0.20 |
| Date: | 2024-09-30 |
| Date: | 2023-12-31 |
| Eps Actual: | -0.4 |
| Date: | 2022-12-31 |
| Eps Actual: | -1.0 |
| Date: | 2021-12-31 |
| Eps Actual: | -0.8 |
| Date: | 2020-12-31 |
| Eps Actual: | -1.1 |
| Date: | 2019-12-31 |
| Eps Actual: | -0.9 |
| Date: | 2018-12-31 |
| Eps Actual: | 0.5 |
| Date: | 2017-12-31 |
| Eps Actual: | -0.9 |